Applied Biotechnology Institute®

HomeProductsKey PersonnelR&DPublicationsPatentsContact Us

 

Key Personnel

John Howard

John Hintze

Patricia Sweeney

Hector Quemada

Cynthia Weick

Atta Ahmad

Erin Egelkrout

 

 

 


John Howard, Ph.D.

   John Howard has 30 years experience in directing biotechnology groups in research, regulatory, production, intellectual property, and business development for two Fortune 500 companies and two Start-up Companies. In addition to directing a number of technology innovations, he also directed the commercial introduction of the first plant biotechnology products for crop improvement and the first industrial and human health products produced from transgenic plants. He is an author on over 100 publications and patents in biotechnology. Currently, Dr. Howard is the Founder and President of Applied Biotechnology Institute, a company focused on providing research and consulting services that help bring plant biotechnology products to various markets with minimal risk.

    Prior to ABI, Dr. Howard founded ProdiGene, a biotechnology company focused on biopharmaceuticals and industrial products from plants. Before forming ProdiGene, Dr. Howard was director of Protein Products at Pioneer Hi-Bred International, Inc., where he initiated and developed a program to develop and produce recombinant protein products from plants. From 1987 to 1994, he was director of the Biotechnology Research Department at Pioneer which included developing new traits and technology for a variety of crops. He began his career at Stauffer Chemical Company in Richmond, California in 1978 to1987, where he initiated and directed a biotechnology research program focused mainly on corn and sunflower. Dr. Howard received his Ph.D. in Biochemistry from the University of California at Riverside.

[Back to Top]


John Hintze, Esq.

    John Hintze is a corporate attorney with over 30 years of experience. He is currently in private practice with a law firm in Des Moines, Iowa where he chairs the Business Law and Transactions Department. He assists clients with the selection of the most appropriate entity for the business or transaction; drafts and reviews documentation for the establishment and operation of the entity selected; and negotiates and drafts transactional documents including the purchase and sale of businesses and/or their assets. Mr. Hintze was formerly the Senior Vice President and General Counsel for Pioneer Hi-Bred International, Inc. from 1984 to 1994. He was responsible for Pioneer's worldwide legal, regulatory and government affairs and business operations. He was also responsible for new business development, human resources, corporate communications, investor relations, community relations, internal audit, and property planning and development.

    Mr. Hintze received his B.A. in accounting from the University of Iowa and his J.D. with distinction from the University of Iowa, College of Law, in 1973. He was admitted to the Iowa Bar in 1973. He is also a Certified Public Accountant. He serves on various boards and has held various community leadership positions.

[Back to Top]


Patricia A. Sweeney, Esq.

    Pat Sweeney is an intellectual property attorney, specializing in biotechnology, with over 20 years of experience. Prior to having her own practice, she was the Chief Patent Counsel at Pioneer Hi-Bred International, Inc. Before working for Pioneer, she practiced with a private intellectual property law firm focusing on patent prosecution and litigation. Currently she advises start-ups and established companies on intellectual property matters, including development of intellectual property strategy; development of in-house systems; integration of international intellectual property issues; freedom to operate analysis; reviewing, monitoring and analyzing competitors’ intellectual property positions; coordinating research planning with intellectual property issues; review opportunities for patent protection; intellectual property portfolio planning; reviewing contracts; training, as well as providing patent prosecution of national and international biotechnology inventions.

    Ms. Sweeney received her J.D. with honors in 1984 from Drake Law School in Des Moines, Iowa. She was admitted to the Iowa Bar in1984 and the Patent Bar in 1987. She is admitted to practice in the Northern and Southern Federal District Courts of Iowa and before the Federal Circuit Court of Appeals. Ms. Sweeney has a B.S. from Iowa State University with a double major in Botany and Journalism/Mass Communications.

[Back to Top]


Hector Quemada, Ph.D.

    Dr. Hector Quemada is the founder and principal consultant for Crop Technology Consulting, Inc., an agricultural biotechnology consulting firm offering services in technical assessment, product development, project management, and regulatory affairs. He is also an Adjunct Professor of Biological Sciences at Western Michigan University, Kalamazoo, Michigan, USA. He is the manager of the Biotechnology and Biodiversity Interface grant program, a component of the Program for Biosafety Systems, led by IFPRI and funded by USAID.

    Dr. Quemada has conducted biotechnology risk assessment research funded by the US Department of Agriculture and under contract to private companies. Dr. Quemada’s consultancies have included technical and biosafety assessments for national biotechnology programs in India, Philippines, Uganda, Kenya, South Africa, and Indonesia, as well as working with the government of Egypt to develop food and environmental safety testing guidelines and regulations for the commercialization of transgenic crops.

[Back to Top]


Cynthia Wagner Weick, Ph.D.

   Cynthia Wagner Weick has over 20 years of experience in the commercialization of new technology, focusing on market analysis, business development and strategic planning. She is currently Professor of Management at University of the Pacific in Stockton, California where she teaches courses in Strategic Management and Policy, Management of Technology and Innovation, New Product Development and Global Competition. As an independent consultant she also performs market analyses of technology-based products and facilitates strategic planning sessions for clients. Weick has written many articles on the international development of commercial biotechnology as well as strategic management. Her book, “Out of Context: A Creative Approach to Strategic Management,” was published in 2004. In 2001 she was named to the Food Biotechnology Advisory Committee of the State of California, which advised the state legislature on biotechnology related issues. She served as a consultant to the United Nations Development Program, where she evaluated the biotechnology research activities within the Consultative Group on International Agriculture (CGIAR). She was a corporate planner at Pioneer Hi-Bred International for four years and worked closely with the company’s executives and research scientists to set strategic directions in biotechnology in the late 1980s.

    Dr. Weick received her B.S. and M.S. in Crop Physiology from the Ohio State University, focusing on plant chemotaxonomy. Her doctorate in Business Administration is from the Wharton School, University of Pennsylvania, where her dissertation regarded the use of international joint ventures in the agricultural biotechnology industry.

[Back to Top]


Atta Ahmad, Ph.D.

    Dr. Ahmad has 13 years experience in laboratory research prior to running a protein chemistry program at ABI. Before coming to ABI, Dr. Ahmad has worked at MIT, Tufts University and UC Santa Cruz where he investigated protein folding and misfolding involved in neurodegenerative diseases such as Alzheimer's and Parkinson's. He received his PhD from the Central Drug Research Institute in India.

[Back to Top]


Erin Egelkrout, Ph.D.

    Dr. Egelkrout has 15 years experience in laboratory research prior to running a molecular biology program at ABI.  Before coming to ABI she worked at the Fred Hutchinson Cancer Research Center in Seattle Washington where she studied the mechanism by which human papillomavirus (HPV) causes degradation of the retinoblastoma tumor suppressor protein (pRb).  She also participated in projects evaluating HPV proteins for use in potential vaccines and the mechanism of HPV induction of telomerase expression.  She received her PhD in Biochemistry from North Carolina State University.

[Back to Top]


 

   

 

 

 

   Last Updated: May 09, 2007

© 2007 Applied Biotechnology Institute All Rights Reserved

Building 36 Cal Poly State University San Luis Obispo, CA 93407 (805) 756-6459